Skip to content

Tag: Preterm labor

Explore our medication guides and pharmacology articles within this category.

How does nifedipine work on the muscles of the uterus?

4 min read
Did you know that nifedipine was first reported for use in tocolysis—the inhibition of uterine contractions—in 1980? This calcium channel blocker is now a first-line therapy for suppressing preterm labor by relaxing the uterine muscles, a key function that helps prolong pregnancy.

How does nifedipine act as a tocolytic?

3 min read
Preterm birth is a leading cause of neonatal morbidity and mortality worldwide. To combat this, medications called tocolytics are used to temporarily inhibit uterine contractions, with nifedipine being a common choice. The primary mechanism for how does nifedipine act as a tocolytic involves blocking the calcium channels necessary for muscle contraction.

Why is nifedipine given to a pregnant woman?

5 min read
Hypertensive disorders of pregnancy have been on the rise, with rates increasing from 13.3% to 15.9% between 2017 and 2019 [1.7.5]. This article explains why is nifedipine given to a pregnant woman to manage some of these critical conditions.

What is Zestdel 200 used for? An Overview of its Medical Uses

4 min read
Progesterone is a vital hormone in the female reproductive cycle, and Zestdel 200 is a natural micronized progesterone medication used to treat various conditions related to hormonal imbalances. This medication addresses issues like menstrual irregularities, infertility, and symptoms of menopause by supplementing progesterone levels.

What Drug Relaxes the Uterus? An Overview of Tocolytic Medications

4 min read
According to the March of Dimes, approximately 1 in 10 babies in the U.S. is born prematurely, highlighting the importance of interventions like tocolytic medications to manage preterm labor. When asking **what drug relaxes the uterus**, the answer involves a specific class of medicines known as tocolytics, which are prescribed to delay childbirth for short, medically necessary periods. These drugs act on uterine muscles to inhibit contractions, providing a critical window for interventions to improve neonatal outcomes.